药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cryptenamine
Potassium perchlorate
The risk or severity of Cardiac Arrhythmia can be increased when Potassium perchlorate is combined with Desipramine.
Cryptenamine
Lemborexant
The serum concentration of Desipramine can be decreased when it is combined with Lemborexant.
Cryptenamine
Levamlodipine
The serum concentration of Levamlodipine can be increased when it is combined with Desipramine.
Cryptenamine
Cenobamate
The serum concentration of Desipramine can be decreased when it is combined with Cenobamate.
Cryptenamine
Bupropion
The risk or severity of seizure can be increased when Desipramine is combined with Bupropion.
Cryptenamine
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Desipramine.
Cryptenamine
Givosiran
The serum concentration of Desipramine can be increased when it is combined with Givosiran.
Cryptenamine
Lasmiditan
The risk or severity of serotonin syndrome can be increased when Desipramine is combined with Lasmiditan.
Cryptenamine
Dronedarone
Desipramine may increase the QTc-prolonging activities of Dronedarone.
Cryptenamine
Escitalopram
The risk or severity of serotonin syndrome can be increased when Desipramine is combined with Escitalopram.
Cryptenamine
Metoclopramide
The risk or severity of sedation can be increased when Metoclopramide is combined with Desipramine.
Cryptenamine
Cyclobenzaprine
The risk or severity of CNS depression can be increased when Desipramine is combined with Cyclobenzaprine.
Cryptenamine
Dalfampridine
The risk or severity of seizure can be increased when Desipramine is combined with Dalfampridine.
Cryptenamine
Lefamulin
Desipramine may increase the QTc-prolonging activities of Lefamulin.
Cryptenamine
Entrectinib
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Entrectinib.
Cryptenamine
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Desipramine.
Cryptenamine
Propacetamol
Desipramine may increase the hepatotoxic activities of Propacetamol.
Cryptenamine
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Desipramine.
Cryptenamine
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Desipramine.
Cryptenamine
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
The risk or severity of adverse effects can be increased when Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione is combined with Desipramine.